These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2936974)
1. Stereoselective blockade at the 5-HT autoreceptor and inhibition of radioligand binding to central 5-HT recognition sites by the optical isomers of methiothepin. Hibert M; Middlemiss DN Neuropharmacology; 1986 Jan; 25(1):1-4. PubMed ID: 2936974 [TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site. Middlemiss DN Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective actions of the isomers of metitepine at 5-HT1D receptors in the guinea pig brain. Wilkinson LO; Hawkins LM; Beer MS; Hibert MF; Middlemiss DN Neuropharmacology; 1993 Mar; 32(3):205-8. PubMed ID: 8474615 [TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Hoyer D; Engel G; Kalkman HO Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410 [TBL] [Abstract][Full Text] [Related]
5. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. Maura G; Roccatagliata E; Ulivi M; Raiteri M Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025 [TBL] [Abstract][Full Text] [Related]
6. The putative 5-HT1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. Middlemiss DN J Pharm Pharmacol; 1985 Jun; 37(6):434-7. PubMed ID: 2862270 [TBL] [Abstract][Full Text] [Related]
7. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function. Pettibone DJ; Pflueger AB J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257 [TBL] [Abstract][Full Text] [Related]
8. The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration. Feuerstein TJ; Lupp A; Hertting G Neuropharmacology; 1987 Aug; 26(8):1071-80. PubMed ID: 2958718 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. Bonanno G; Maura G; Raiteri M Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750 [TBL] [Abstract][Full Text] [Related]
10. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain. Waldmeier PC; Williams M; Baumann PA; Bischoff S; Sills MA; Neale RF Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):609-20. PubMed ID: 2905765 [TBL] [Abstract][Full Text] [Related]
11. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype. Maura G; Barzizza A; Folghera S; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Middlemiss DN Eur J Pharmacol; 1984 Jun; 101(3-4):289-93. PubMed ID: 6468503 [TBL] [Abstract][Full Text] [Related]
13. Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Maura G; Roccatagliata E; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):323-6. PubMed ID: 3821924 [TBL] [Abstract][Full Text] [Related]
14. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex. Bühlen M; Fink K; Böing C; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282 [TBL] [Abstract][Full Text] [Related]
15. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Hervás I; Queiroz CM; Adell A; Artigas F Br J Pharmacol; 2000 May; 130(1):160-6. PubMed ID: 10781012 [TBL] [Abstract][Full Text] [Related]
16. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. Raiteri M; Maura G; Bonanno G; Pittaluga A J Pharmacol Exp Ther; 1986 May; 237(2):644-8. PubMed ID: 2871177 [TBL] [Abstract][Full Text] [Related]
17. Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. Chaput Y; de Montigny C J Pharmacol Exp Ther; 1988 Jul; 246(1):359-70. PubMed ID: 2839669 [TBL] [Abstract][Full Text] [Related]
18. Characterization of 5-hydroxytryptamine receptors on the isolated pig basilar artery by functional and radioligand binding studies. Miyamoto A; Sakota T; Nishio A Jpn J Pharmacol; 1994 Jul; 65(3):265-73. PubMed ID: 7799527 [TBL] [Abstract][Full Text] [Related]
19. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714 [TBL] [Abstract][Full Text] [Related]
20. Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. Houston DS; Vanhoutte PM J Pharmacol Exp Ther; 1988 Jan; 244(1):1-10. PubMed ID: 2961880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]